Free tool
Dollar-cost averaging calculator
Pick an amount to invest each month, then change the share price for each of six months. The calculator shows how many shares each month buys, your average cost per share, and what the shares are worth at the last price.
By Quoliv · Beginner investing lessons and fake-money practice from the maker of Quoliv. · Updated
Share price each month (change them)
10.00 shares
12.50 shares
20.00 shares
12.50 shares
10.00 shares
8.33 shares
Your average cost per share
$8.18
Average share price
$8.83
Total invested
$600
Value at the last price
$880
The same amount buys more shares when the price is low, so your average cost usually ends up below the average price.
The worked example above
Investing $100 a month at prices of $10, $8, $5, $8, $10, and $12 buys about 73.3 shares for $600. Your average cost is about $8.18 a share, lower than the average price of $8.83, because the $5 month bought twice as many shares as a $10 month. At the last price of $12, the shares are worth about $880.
What dollar-cost averaging does and does not do
It removes the need to guess the right day to invest, and it means falling prices buy you more shares. It does not guarantee a profit: if the price keeps falling and never recovers, you still lose money. Try entering prices that only go down to see that. Our guide to dollar-cost averaging covers the idea in plain English.
DCA versus investing everything at once
If prices rise steadily, putting all the money in at the start usually ends with more, because it is invested for longer. DCA tends to win when prices dip early. Nobody knows which will happen, which is why many beginners like a fixed monthly habit. To see a monthly habit over decades, use the compound interest calculator.
Practise without real money
Quoliv has a two-minute lesson on dollar-cost averaging and a fake-money simulator with real prices, so you can try a monthly buying habit without risk. It is free and never asks for bank details.
Quoliv is for education and fake-money practice. It does not recommend securities or provide personal financial advice. Read our editorial policy.